Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CC Chemokine Receptor Type 5 (CCR5) is a G-protein coupled receptor primarily expressed on T cells, macrophages, and dendritic cells. It plays a central role in immune surveillance and inflammatory responses by directing the migration of immune cells to sites of inflammation through interaction with its chemokine ligands, including CCL3, CCL4, CCL3L1, CCL5, and MCP-2. CCR5 also serves as a critical co-receptor for entry of macrophage-tropic strains of HIV-1. Beyond infectious disease, CCR5 contributes to pathogenesis in inflammatory diseases and cancer, particularly triple-negative breast cancer. Emerging evidence suggests that CCR5 modulates learning/memory processes as well.
CCR5 antagonism
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CC Chemokine Receptor Type 5.